This announcement is a separate document:
南京南大药业有限责任公司2022年1月-2024年4月审计报告
Audit report from January 2022 to April 2024 for Nanjing Nanda Pharmaceutical Co., Ltd.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.